Recent advances in prenatal genetic screening and testing

F1000Research

Volumn 5, Issue , 2016, Pages

  Van den Veyver, Ignatia B ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Genetic abnormalities; Pregnancy; Prenatal screening; Risk

Indexed keywords

EID: 85020084631     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.9215.1     Document Type: Review

References (145)

1. Benn P Borrell A Chiu RW: Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn. 2015;35(8):725-34. 25970088 10.1002/pd.4608
2. Practice Bulletin No. 163 Summary: Screening for Fetal Aneuploidy. Obstet Gynecol. 2016;127(5):979-81. 27101120 10.1097/AOG.0000000000001439
3. Grody WW Thompson BH Gregg AR: ACMG position statement on prenatal/preconception expanded carrier screening. Genet Med. 2013;15(6):482-3. 23619275 10.1038/gim.2013.47
4. Van den Veyver IB Patel A Shaw CA: Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases. Prenat Diagn. 2009;29(1):29-39. 19012303 10.1002/pd.2127 3665952
5. Breman A Pursley AN Hixson P: Prenatal chromosomal microarray analysis in a diagnostic laboratory; experience with >1000 cases and review of the literature. Prenat Diagn. 2012;32(4):351-61. 22467166 10.1002/pd.3861
6. Wapner RJ Martin CL Levy B: Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367(23):2175-84. 23215555 10.1056/NEJMoa1203382 3549418
7. Van den Veyver IB Eng CM: Genome-Wide Sequencing for Prenatal Detection of Fetal Single-Gene Disorders. Cold Spring Harb Perspect Med. 2015;5(10): pii: a023077. 26253094 10.1101/cshperspect.a023077
8. Carss KJ Hillman SC Parthiban V: Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound. Hum Mol Genet. 2014;23(12):3269-77. 24476948 10.1093/hmg/ddu038 4030780
9. Hillman SC Willams D Carss KJ: Prenatal exome sequencing for fetuses with structural abnormalities: the next step. Ultrasound Obstet Gynecol. 2015;45(1):4-9. 25157891 10.1002/uog.14653
10. Talkowski ME Ordulu Z Pillalamarri V: Clinical diagnosis by whole-genome sequencing of a prenatal sample. N Engl J Med. 2012;367(23):2226-32. 23215558 10.1056/NEJMoa1208594 3579222
11. Drury S Williams H Trump N: Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities. Prenat Diagn. 2015;35(10):1010-7. 26275891 10.1002/pd.4675
12. Ellard S Kivuva E Turnpenny P: An exome sequencing strategy to diagnose lethal autosomal recessive disorders. Eur J Hum Genet. 2015;23(3):401-4. 24961629 10.1038/ejhg.2014.120 4205099
13. Filges I Friedman JM: Exome sequencing for gene discovery in lethal fetal disorders--harnessing the value of extreme phenotypes. Prenat Diagn. 2015;35(10):1005-9. 25046514 10.1002/pd.4464
14. Stankiewicz P Beaudet AL: Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation. Curr Opin Genet Dev. 2007;17(3):182-92. 17467974 10.1016/j.gde.2007.04.009
15. Lee H Deignan JL Dorrani N: Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA. 2014;312(18):1880-7. 25326637 10.1001/jama.2014.14604 4278636
16. Gilissen C Hehir-Kwa JY Thung DT: Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014;511(7509):344-7. 24896178 10.1038/nature13394
17. Beaulieu CL Majewski J Schwartzentruber J: FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project. Am J Hum Genet. 2014;94(6):809-17. 24906018 10.1016/j.ajhg.2014.05.003 4121481
18. Westerfield LE Stover SR Mathur VS: Reproductive genetic counseling challenges associated with diagnostic exome sequencing in a large academic private reproductive genetic counseling practice. Prenat Diagn. 2015;35(10):1022-9. 26275793 10.1002/pd.4674
19. Hui L Bianchi DW: Recent advances in the prenatal interrogation of the human fetal genome. Trends Genet. 2013;29(2):84-91. 23158400 10.1016/j.tig.2012.10.013 4378900
20. McGillivray G Rosenfeld JA McKinlay Gardner RJ: Genetic counselling and ethical issues with chromosome microarray analysis in prenatal testing. Prenat Diagn. 2012;32(4):389-95. 22467169 10.1002/pd.3849
21. Dondorp W Sikkema-Raddatz B de Die-Smulders C: Arrays in postnatal and prenatal diagnosis: An exploration of the ethics of consent. Hum Mutat. 2012;33(6):916-22. 22396320 10.1002/humu.22068
22. Miller DT Adam MP Aradhya S: Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749-64. 20466091 10.1016/j.ajhg.2010.04.006 2869000
23. Hillman SC McMullan DJ Hall G: Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2013;41(6):610-20. 23512800 10.1002/uog.12464
24. Reddy UM Page GP Saade GR: Karyotype versus microarray testing for genetic abnormalities after stillbirth. N Engl J Med. 2012;367(23):2185-93. 23215556 10.1056/NEJMoa1201569 4295117
25. American College of Obstetricians and Gynecologists Committee on Genetics: Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstet Gynecol. 2013;122(6):1374-7. 24264715 10.1097/01.AOG.0000438962.16108.d1
26. Dhillon RK Hillman SC Morris RK: Additional information from chromosomal microarray analysis (CMA) over conventional karyotyping when diagnosing chromosomal abnormalities in miscarriage: a systematic review and meta-analysis. BJOG. 2014;121(1):11-21. 23859082 10.1111/1471-0528.12382
27. American College of Obstetricians and Gynecologists: ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol. 2007;110(6):1459-67. 18055749 10.1097/01.AOG.0000291570.63450.44
28. Akolekar R Beta J Picciarelli G: Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;45(1):16-26. 25042845 10.1002/uog.14636
29. Wulff CB Gerds TA Rode L: Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies. Ultrasound Obstet Gynecol. 2016;47(1):38-44. 26581188 10.1002/uog.15820
30. Rose NC Lagrave D Hafen B: The impact of utilization of early aneuploidy screening on amniocenteses available for training in obstetrics and fetal medicine. Prenat Diagn. 2013;33(3):242-4. 23354826 10.1002/pd.4052
31. Bianchi DW Simpson JL Jackson LG: Fetal cells in maternal blood: NIFTY clinical trial interim analysis. DM-STAT. NICHD fetal cell study (NIFTY) group. Prenat Diagn. 1999;19(10):994-5. 10521832 10.1002/(SICI)1097-0223(199910)19:10<994::AID-PD662>3.0.CO;2-H
32. Lo YM Corbetta N Chamberlain PF: Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485-7. 9274585 10.1016/S0140-6736(97)02174-0
33. Costa JM Benachi A Gautier E: New strategy for prenatal diagnosis of X-linked disorders. N Engl J Med. 2002;346(19):1502. 12000828 10.1056/NEJM200205093461918
34. Lo YM Hjelm NM Fidler C: Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med. 1998;339(24):1734-8. 9845707 10.1056/NEJM199812103392402
35. Bianchi DW Avent ND Costa JM: Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time. Obstet Gynecol. 2005;106(4):841-4. 16199645 10.1097/01.AOG.0000179477.59385.93
36. Geifman-Holtzman O Grotegut CA Gaughan JP: Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis. Am J Obstet Gynecol. 2006;195(4):1163-73. 17000250 10.1016/j.ajog.2006.07.033
37. Daniels G Finning K Martin P: Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenat Diagn. 2009;29(2):101-7. 19085963 10.1002/pd.2172
38. Moise KJ Jr Boring NH O'Shaughnessy R: Circulating cell-free fetal DNA for the detection of RHD status and sex using reflex fetal identifiers. Prenat Diagn. 2013;33(1):95-101. 23225162 10.1002/pd.4018
39. Grande M Ordoñez E Cirigliano V: Clinical application of midtrimester non-invasive fetal RHD genotyping and identification of RHD variants in a mixed-ethnic population. Prenat Diagn. 2013;33(2):173-8. 23280558 10.1002/pd.4035
40. González-González MC Garcia-Hoyos M Trujillo MJ: Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn. 2002;22(10):946-8. 12378583 10.1002/pd.439
41. Chitty LS Khalil A Barrett AN: Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA. Prenat Diagn. 2013;33(5):416-23. 23408600 10.1002/pd.4066 4166694
42. Chitty LS Mason S Barrett AN: Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach. Prenat Diagn. 2015;35(7):656-62. 25728633 10.1002/pd.4583 4657458
43. Xiong L Barrett AN Hua R: Non-invasive prenatal diagnostic testing for β-thalassaemia using cell-free fetal DNA and next generation sequencing. Prenat Diagn. 2015;35(3):258-65. 25400264 10.1002/pd.4536
44. Hill M Twiss P Verhoef TI: Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis. Prenat Diagn. 2015;35(10):950-8. 25708280 10.1002/pd.4585 4672687
45. Fan HC Blumenfeld YJ Chitkara U: Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A. 2008;105(42):16266-71. 18838674 10.1073/pnas.0808319105 2562413
46. Chiu RW Chan KC Gao Y: Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A. 2008;105(51):20458-63. 19073917 10.1073/pnas.0810641105 2600580
47. Chiu RW Akolekar R Zheng YW: Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ. 2011;342:c7401. 21224326 10.1136/bmj.c7401
48. Palomaki GE Kloza EM Lambert-Messerlian GM: DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med. 2011;13(11):913-20. 22005709 10.1097/GIM.0b013e3182368a0e
49. Palomaki GE Deciu C Kloza EM: DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med. 2012;14(3):296-305. 22281937 10.1038/gim.2011.73 3938175
50. Bianchi DW Platt LD Goldberg JD: Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol. 2012;119(5):890-901. 22362253 10.1097/AOG.0b013e31824fb482
51. Liang D Lv W Wang H: Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing. Prenat Diagn. 2013;33(5):409-15. 23299662 10.1002/pd.4033
52. Song Y Liu C Qi H: Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population. Prenat Diagn. 2013;33(7):700-6. 23703459 10.1002/pd.4160
53. Mazloom AR Dzakula Z Oeth P: Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. Prenat Diagn. 2013;33(6):591-7. 23592550 10.1002/pd.4127
54. Stumm M Entezami M Haug K: Diagnostic accuracy of random massively parallel sequencing for non-invasive prenatal detection of common autosomal aneuploidies: a collaborative study in Europe. Prenat Diagn. 2014;34(2):185-91. 24222400 10.1002/pd.4278
55. Grati FR Ferreira JC Bajaj K: Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol. 2014;211(6):711-2. 25025943 10.1016/j.ajog.2014.07.015
56. Bianchi DW Parker RL Wentworth J: DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med. 2014;370(9):799-808. 24571752 10.1056/NEJMoa1311037
57. Zimmermann B Hill M Gemelos G: Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn. 2012;32(13):1233-41. 23108718 10.1002/pd.3993 3548605
58. Ashoor G Syngelaki A Wagner M: Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol. 2012;206(4):322.e1-5. 22464073 10.1016/j.ajog.2012.01.029
59. Nicolaides KH Syngelaki A Ashoor G: Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol. 2012;207(5):374.e1-6. 23107079 10.1016/j.ajog.2012.08.033
60. Ashoor G Syngelaki A Wang E: Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method. Ultrasound Obstet Gynecol. 2013;41(1):21-5. 22996646 10.1002/uog.12299
61. Nicolaides KH Syngelaki A Gil M: Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenat Diagn. 2013;33(6):575-9. 23613152 10.1002/pd.4103
62. Pergament E Cuckle H Zimmermann B: Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort. Obstet Gynecol. 2014;124(2 Pt 1):210-8. 25004354 10.1097/AOG.0000000000000363 4144440
63. Verweij EJ Jacobsson B van Scheltema PA: European non-invasive trisomy evaluation (EU-NITE) study: a multicenter prospective cohort study for non-invasive fetal trisomy 21 testing. Prenat Diagn. 2013;33(10):996-1001. 23794121 10.1002/pd.4182
64. Nicolaides KH Musci TJ Struble CA: Assessment of fetal sex chromosome aneuploidy using directed cell-free DNA analysis. Fetal Diagn Ther. 2014;35(1):1-6. 24335155 10.1159/000357198
65. Norton ME Jacobsson B Swamy GK: Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med. 2015;372(17):1589-97. 25830321 10.1056/NEJMoa1407349
66. del Mar Gil M Quezada MS Bregant B: Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies. Fetal Diagn Ther. 2014;35(3):204-11. 24247435 10.1159/000356495
67. Dan S Wang W Ren J: Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn. 2012;32(13):1225-32. 23138752 10.1002/pd.4002
68. Dar P Curnow KJ Gross SJ: Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol. 2014;211(5):527.e1-527.e17. 25111587 10.1016/j.ajog.2014.08.006
69. Zhang H Gao Y Jiang F: Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol. 2015;45(5):530-8. 25598039 10.1002/uog.14792
70. Wang J Sahoo T Schonberg S: Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases. Genet Med. 2015;17(3):234-6. 25101914 10.1038/gim.2014.92
71. Cheung SW Patel A Leung TY: Accurate description of DNA-based noninvasive prenatal screening. N Engl J Med. 2015;372(17):1675-7. 25830325 10.1056/NEJMc1412222
72. Bianchi DW Wilkins-Haug L: Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road? Clin Chem. 2014;60(1):78-87. 24255077 10.1373/clinchem.2013.202663 4827766
73. Curnow KJ Wilkins-Haug L Ryan A: Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test. Am J Obstet Gynecol. 2015;212(1):79.e1-9. 25447960 10.1016/j.ajog.2014.10.012
74. Grati FR Malvestiti F Ferreira JC: Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med. 2014;16(8):620-4. 24525917 10.1038/gim.2014.3
75. Hall AL Drendel HM Verbrugge JL: Positive cell-free fetal DNA testing for trisomy 13 reveals confined placental mosaicism. Genet Med. 2013;15(9):729-32. 23492874 10.1038/gim.2013.26
76. Choi H Lau TK Jiang FM: Fetal aneuploidy screening by maternal plasma DNA sequencing: 'false positive' due to confined placental mosaicism. Prenat Diagn. 2013;33(2):198-200. 23192749 10.1002/pd.4024
77. Taglauer ES Wilkins-Haug L Bianchi DW: Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease. Placenta. 2014;35(Suppl):S64-8. 24388429 10.1016/j.placenta.2013.11.014 4886648
78. Russell LM Strike P Browne CE: X chromosome loss and ageing. Cytogenet Genome Res. 2007;116(3):181-5. 17317957 10.1159/000098184
79. Bianchi DW Parsa S Bhatt S: Fetal sex chromosome testing by maternal plasma DNA sequencing: clinical laboratory experience and biology. Obstet Gynecol. 2015;125(2):375-82. 25568992 10.1097/AOG.0000000000000637
80. Palomaki GE Kloza EM Lambert-Messerlian GM: Circulating cell free DNA testing: are some test failures informative? Prenat Diagn. 2015;35(3):289-93. 25449554 10.1002/pd.4541
81. Rava RP Srinivasan A Sehnert AJ: Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X. Clin Chem. 2014;60(1):243-50. 24046201 10.1373/clinchem.2013.207951
82. Canick JA Palomaki GE Kloza EM: The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenat Diagn. 2013;33(7):667-74. 23592541 10.1002/pd.4126
83. Ashoor G Syngelaki A Poon LC: Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol. 2013;41(1):26-32. 23108725 10.1002/uog.12331
84. Osborne CM Hardisty E Devers P: Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn. 2013;33(6):609-11. 23559449 10.1002/pd.4100
85. Bianchi DW Chudova D Sehnert AJ: Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies. JAMA. 2015;314(2):162-9. 26168314 10.1001/jama.2015.7120
86. Snyder HL Curnow KJ Bhatt S: Follow-up of multiple aneuploidies and single monosomies detected by noninvasive prenatal testing: implications for management and counseling. Prenat Diagn. 2016;36(3):203-9. 26785403 10.1002/pd.4778
87. McCullough RM Almasri EA Guan X: Non-invasive prenatal chromosomal aneuploidy testing--clinical experience: 100,000 clinical samples. PLoS One. 2014;9(10):e109173. 25289665 10.1371/journal.pone.0109173 4188614
88. Peters D Chu T Yatsenko SA: Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. N Engl J Med. 2011;365(19):1847-8. 22070496 10.1056/NEJMc1106975 4308687
89. Jensen TJ Dzakula Z Deciu C: Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma. Clin Chem. 2012;58(7):1148-51. 22563040 10.1373/clinchem.2011.180794
90. Chen S Lau TK Zhang C: A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing. Prenat Diagn. 2013;33(6):584-90. 23592436 10.1002/pd.4110
91. Srinivasan A Bianchi DW Huang H: Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet. 2013;92(2):167-76. 23313373 10.1016/j.ajhg.2012.12.006 3567270
92. Yu SC Jiang P Choy KW: Noninvasive prenatal molecular karyotyping from maternal plasma. PLoS One. 2013;8(4):e60968. 23613765 10.1371/journal.pone.0060968 3629174
93. Vora NL O'Brien BM: Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: proceed with caution. Obstet Gynecol. 2014;123(5):1097-9. 24785862 10.1097/AOG.0000000000000237
94. Gregg AR Van den Veyver IB Gross SJ: Noninvasive prenatal screening by next-generation sequencing. Annu Rev Genomics Hum Genet. 2014;15:327-47. 24849140 10.1146/annurev-genom-090413-025341
95. Gross SJ Ryan A Benn P: Noninvasive prenatal testing for 22q11.2 deletion syndrome: deeper sequencing increases the positive predictive value. Am J Obstet Gynecol. 2015;213(2):254-5. 25986033 10.1016/j.ajog.2015.05.028
96. Wapner RJ Babiarz JE Levy B: Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes. Am J Obstet Gynecol. 2015;212(3):332.e1-9. 25479548 10.1016/j.ajog.2014.11.041
97. Yaron Y Jani J Schmid M: Current Status of Testing for Microdeletion Syndromes and Rare Autosomal Trisomies Using Cell-Free DNA Technology. Obstet Gynecol. 2015;126(5):1095-9. 26444108 10.1097/AOG.0000000000001091
98. Helgeson J Wardrop J Boomer T: Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing. Prenat Diagn. 2015;35(10):999-1004. 26088833 10.1002/pd.4640 5034801
99. Benn P: Posttest risk calculation following positive noninvasive prenatal screening using cell-free DNA in maternal plasma. Am J Obstet Gynecol. 2016;214(6):676.e1-7. 26772793 10.1016/j.ajog.2016.01.003
100. Zhao C Tynan J Ehrich M: Detection of fetal subchromosomal abnormalities by sequencing circulating cell-free DNA from maternal plasma. Clin Chem. 2015;61(4):608-16. 25710461 10.1373/clinchem.2014.233312
101. Lefkowitz RB Tynan JA Liu T: Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants. Am J Obstet Gynecol. 2016;215(2):227.e1-227.e16. 26899906 10.1016/j.ajog.2016.02.030
102. Yatsenko SA Peters DG Saller DN: Maternal cell-free DNA-based screening for fetal microdeletion and the importance of careful diagnostic follow-up. Genet Med. 2015;17(10):836-8. 25569438 10.1038/gim.2014.197 4496325
103. Sahoo T Hovanes K Strecker MN: Expanding noninvasive prenatal testing to include microdeletions and segmental aneuploidy: cause for concern? Genet Med. 2016;18(3):275-6. 26795592 10.1038/gim.2015.196
104. Wilson KL Czerwinski JL Hoskovec JM: NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy. J Genet Couns. 2013;22(1):4-15. 23179172 10.1007/s10897-012-9545-3
105. Gregg AR Gross SJ Best RG: ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med. 2013;15(5):395-8. 23558255 10.1038/gim.2013.29
106. Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy. Obstet Gynecol. 2015;126(3):e31-7. 26287791 10.1097/AOG.0000000000001051
107. Dondorp W de Wert G Bombard Y: Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur J Hum Genet. 2015;23(11):1438-50. 25782669 10.1038/ejhg.2015.57 4613463
108. Gregg AR Skotko BG Benkendorf JL: Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016;18(10):1056-65. 27467454 10.1038/gim.2016.97
109. Alamillo CM Krantz D Evans M: Nearly a third of abnormalities found after first-trimester screening are different than expected: 10-year experience from a single center. Prenat Diagn. 2013;33(3):251-6. 23354915 10.1002/pd.4054
110. Norton ME Jelliffe-Pawlowski LL Currier RJ: Chromosome abnormalities detected by current prenatal screening and noninvasive prenatal testing. Obstet Gynecol. 2014;124(5):979-86. 25437727 10.1097/AOG.0000000000000452
111. Benn P Norwitz ER Pergament E: Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities. Am J Obstet Gynecol. 2016;215(2):252-3. 27091082 10.1016/j.ajog.2016.04.012
112. Caine A Maltby AE Parkin CA: Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment. Lancet. 2005;366(9480):123-8. 16005334 10.1016/S0140-6736(05)66790-6
113. Petersen OB Vogel I Ekelund C: Potential diagnostic consequences of applying non-invasive prenatal testing: population-based study from a country with existing first-trimester screening. Ultrasound Obstet Gynecol. 2014;43(3):265-71. 24375770 10.1002/uog.13270
114. Singh ON: Clinical experience and follow-up with large-scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol. 2015;213(2):253. 25940612 10.1016/j.ajog.2015.04.039
115. Dar P Gross SJ Benn P: Reply: To PMID 25111587. Am J Obstet Gynecol. 2015;213(2):253-4. 25940611 10.1016/j.ajog.2015.04.040
116. American College of Obstetricians and Gynecologists Committee on Genetics: ACOG Committee Opinion No. 469: Carrier screening for fragile X syndrome. Obstet Gynecol. 2010;116(4):1008-10. 20859177 10.1097/AOG.0b013e3181fae884
117. American College of Obstetricians and Gynecologists Committee on Genetics: ACOG Committee Opinion No. 486: Update on carrier screening for cystic fibrosis. Obstet Gynecol. 2011;117(4):1028-31. 21422883 10.1097/AOG.0b013e31821922c2
118. Prior TW Professional Practice and Guidelines Committee: Carrier screening for spinal muscular atrophy. Genet Med. 2008;10(11):840-2. 18941424 10.1097/GIM.0b013e318188d069 3110347
119. Gross SJ Pletcher BA Monaghan KG: Carrier screening in individuals of Ashkenazi Jewish descent. Genet Med. 2008;10(1):54-6. 18197057 10.1097/GIM.0b013e31815f247c 3110977
120. Edwards JG Feldman G Goldberg J: Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine. Obstet Gynecol. 2015;125(3):653-62. 25730230 10.1097/AOG.0000000000000666
121. Langlois S Benn P Wilkins-Haug L: Current controversies in prenatal diagnosis 4: pre-conception expanded carrier screening should replace all current prenatal screening for specific single gene disorders. Prenat Diagn. 2015;35(1):23-8. 25395388 10.1002/pd.4532
122. Lazarin GA Haque IS Nazareth S: An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals. Genet Med. 2013;15(3):178-86. 22975760 10.1038/gim.2012.114 3908551
123. Bell CJ Dinwiddie DL Miller NA: Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med. 2011;3(65):65ra4. 21228398 10.1126/scitranslmed.3001756 3740116
124. Martin J Asan Yi Y: Comprehensive carrier genetic test using next-generation deoxyribonucleic acid sequencing in infertile couples wishing to conceive through assisted reproductive technology. Fertil Steril. 2015;104(5):1286-93. 26354092 10.1016/j.fertnstert.2015.07.1166
125. Lazarin GA Goldberg JD: Current controversies in traditional and expanded carrier screening. Curr Opin Obstet Gynecol. 2016;28(2):136-41. 26844860 10.1097/GCO.0000000000000256
126. Pergament E Alamillo C Sak K: Genetic assessment following increased nuchal translucency and normal karyotype. Prenat Diagn. 2011;31(3):307-10. 21321969 10.1002/pd.2718
127. Alamillo CM Fiddler M Pergament E: Increased nuchal translucency in the presence of normal chromosomes: what's next? Curr Opin Obstet Gynecol. 2012;24(2):102-8. 22277886 10.1097/GCO.0b013e3283505b25
128. Yang Y Muzny DM Xia F: Molecular findings among patients referred for clinical whole-exome sequencing. JAMA. 2014;312(18):1870-9. 25326635 10.1001/jama.2014.14601 4326249
129. Yang Y Muzny DM Reid JG: Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med. 2013;369(16):1502-11. 24088041 10.1056/NEJMoa1306555 4211433
130. Ravenscroft G Nolent F Rajagopalan S: Mutations of GPR126 are responsible for severe arthrogryposis multiplex congenita. Am J Hum Genet. 2015;96(6):955-61. 26004201 10.1016/j.ajhg.2015.04.014 4457946
131. Slavotinek A Kaylor J Pierce H: CRB2 mutations produce a phenotype resembling congenital nephrosis, Finnish type, with cerebral ventriculomegaly and raised alpha-fetoprotein. Am J Hum Genet. 2015;96(1):162-9. 25557780 10.1016/j.ajhg.2014.11.013 4289687
132. Mejlachowicz D Nolent F Maluenda J: Truncating Mutations of MAGEL2, a Gene within the Prader-Willi Locus, Are Responsible for Severe Arthrogryposis. Am J Hum Genet. 2015;97(4):616-20. 26365340 10.1016/j.ajhg.2015.08.010 4596890
133. Poirier K Martinovic J Laquerrière A: Rare ACTG1 variants in fetal microlissencephaly. Eur J Med Genet. 2015;58(8):416-8. 26188271 10.1016/j.ejmg.2015.06.006
134. Filges I Nosova E Bruder E: Exome sequencing identifies mutations in KIF14 as a novel cause of an autosomal recessive lethal fetal ciliopathy phenotype. Clin Genet. 2014;86(3):220-8. 24128419 10.1111/cge.12301
135. Alamillo CL Powis Z Farwell K: Exome sequencing positively identified relevant alterations in more than half of cases with an indication of prenatal ultrasound anomalies. Prenat Diagn. 2015;35(11):1073-8. 26147564 10.1002/pd.4648
136. Fan HC Gu W Wang J: Non-invasive prenatal measurement of the fetal genome. Nature. 2012;487(7407):320-4. 22763444 10.1038/nature11251 3561905
137. Kitzman JO Snyder MW Ventura M: Noninvasive whole-genome sequencing of a human fetus. Sci Transl Med. 2012;4(137):137ra76. 22674554 10.1126/scitranslmed.3004323 3379884
138. Mouawia H Saker A Jais JP: Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy. Reprod Biomed Online. 2012;25(5):508-20. 23000084 10.1016/j.rbmo.2012.08.002
139. Hatt L Brinch M Singh R: Characterization of fetal cells from the maternal circulation by microarray gene expression analysis--could the extravillous trophoblasts be a target for future cell-based non-invasive prenatal diagnosis? Fetal Diagn Ther. 2014;35(3):218-27. 24217417 10.1159/000356073
140. Beaudet AL: Using fetal cells for prenatal diagnosis: History and recent progress. Am J Med Genet C Semin Med Genet. 2016;172(2):123-7. 27133782 10.1002/ajmg.c.31487
141. Bi W Breman A Shaw CA: Detection of ≥1Mb microdeletions and microduplications in a single cell using custom oligonucleotide arrays. Prenat Diagn. 2012;32(1):10-20. 22470934 10.1002/pd.2855
142. Hatt L Brinch M Singh R: A new marker set that identifies fetal cells in maternal circulation with high specificity. Prenat Diagn. 2014;34(11):1066-72. 24912661 10.1002/pd.4429
143. Schlütter JM Kirkegaard I Petersen OB: Fetal gender and several cytokines are associated with the number of fetal cells in maternal blood--an observational study. PLoS One. 2014;9(9):e106934. 25188498 10.1371/journal.pone.0106934 4154776
144. Emad A Bouchard EF Lamoureux J: Validation of automatic scanning of microscope slides in recovering rare cellular events: application for detection of fetal cells in maternal blood. Prenat Diagn. 2014;34(6):538-46. 24578229 10.1002/pd.4345
145. Emad A Drouin R: Evaluation of the impact of density gradient centrifugation on fetal cell loss during enrichment from maternal peripheral blood. Prenat Diagn. 2014;34(9):878-85. 24752776 10.1002/pd.4387